Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 · kind B2 · utility
49Cited by
20References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2013 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | Aug 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.